The influence of genetic risk for obesity on food choice behaviors is unknown and may be in the causal pathway between genetic risk and weight gain. The aim of this study was to examine associations between genetic risk for obesity and food choice behaviors using objectively assessed workplace food purchases.
Methods and findings
This study is a secondary analysis of baseline data collected prior to the start of the “ChooseWell 365” health-promotion intervention randomized control trial. Participants were employees of a large hospital in Boston, MA, who enrolled in the study between September 2016 and February 2018. Cafeteria sales data, collected retrospectively for 3 months prior to enrollment, were used to track the quantity (number of items per 3 months) and timing (median time of day) of purchases, and participant surveys provided self-reported behaviors, including skipping meals and preparing meals at home. A previously validated Healthy Purchasing Score was calculated using the cafeteria traffic-light labeling system (i.e., green = healthy, yellow = less healthy, red = unhealthy) to estimate the healthfulness (quality) of employees’ purchases (range, 0%–100% healthy). DNA was extracted and genotyped from blood samples. A body mass index (BMI) genome-wide polygenic score (BMIGPS) was generated by summing BMI-increasing risk alleles across the genome. Additionally, 3 polygenic risk scores (PRSs) were generated with 97 BMI variants previously identified at the genome-wide significance level (P < 5 × 10−8): (1) BMI97 (97 loci), (2) BMICNS (54 loci near genes related to central nervous system [CNS]), and (3) BMInon-CNS (43 loci not related to CNS). Multivariable linear and logistic regression tested associations of genetic risk score quartiles with workplace purchases, adjusted for age, sex, seasonality, and population structure. Associations were considered significant at P < 0.05. In 397 participants, mean age was 44.9 years, and 80.9% were female. Higher genetic risk scores were associated with higher BMI. The highest quartile of BMIGPS was associated with lower Healthy Purchasing Score (−4.8 percentage points [95% CI −8.6 to −1.0]; P = 0.02), higher quantity of food purchases (14.4 more items [95% CI −0.1 to 29.0]; P = 0.03), later time of breakfast purchases (15.0 minutes later [95% CI 1.5–28.5]; P = 0.03), and lower likelihood of preparing dinner at home (Q4 odds ratio [OR] = 0.3 [95% CI 0.1–0.9]; P = 0.03) relative to the lowest BMIGPS quartile. Compared with the lowest quartile, the highest BMICNS quartile was associated with fewer items purchased (P = 0.04), and the highest BMInon-CNS quartile was associated with purchasing breakfast at a later time (P = 0.01), skipping breakfast (P = 0.03), and not preparing breakfast (P = 0.04) or lunch (P = 0.01) at home. A limitation of this study is our data come from a relatively small sample of healthy working adults of European ancestry who volunteered to enroll in a health-promotion study, which may limit generalizability.
In this study, genetic risk for obesity was associated with the quality, quantity, and timing of objectively measured workplace food purchases. These findings suggest that genetic risk for obesity may influence eating behaviors that contribute to weight and could be targeted in personalized workplace wellness programs in the future.
Why was this study done?
- Genetics play a role in the development of obesity, yet the influence of genetic risk for obesity on food choice behaviors is not well understood.
- Workplace cafeteria purchasing data provided an opportunity for objective, real-time assessment of employees’ food choices.
What did the researchers do and find?
- We conducted a secondary analysis of baseline data of cafeteria food purchases prior to the start of a workplace intervention in a health-promotion randomized control trial using data from 397 employees who accepted to provide DNA for genetic analyses.
- We observed that the highest quartile of a genome-wide polygenic score for body mass index (highest genetic risk for obesity) was associated with lower dietary quality of all purchases, higher quantity of food purchases, later time of breakfast purchases, and lower likelihood of preparing dinner at home relative to the lowest quartile.
Citation: Dashti HS, Hivert M-F, Levy DE, McCurley JL, Saxena R, Thorndike AN (2020) Polygenic risk score for obesity and the quality, quantity, and timing of workplace food purchases: A secondary analysis from the ChooseWell 365 randomized trial. PLoS Med 17(7): e1003219. https://doi.org/10.1371/journal.pmed.1003219
Academic Editor: Sanjay Basu, Harvard Medical School, UNITED STATES
Received: January 24, 2020; Accepted: June 18, 2020; Published: July 21, 2020
Copyright: © 2020 Dashti et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: Data cannot be shared publicly at this time because our data contains potentially identifying participant information. The study population is a relatively small cohort of employees at Massachusetts General Hospital (a named institution in the manuscript) enrolled in the ChooseWell 365 RCT during a recent time period. Sharing information on individuals’ age, sex, dates, timing of cafeteria purchases, and BMI will compromise participant privacy. Data are available from the Partners Human Research Office/Institutional Review Board at Partners HealthCare (contact located at https://www.partners.org/Medical-Research/Support-Offices/Human-Research-Committee-IRB/Default.aspx) for researchers who meet the criteria for access to confidential data.
Funding: ANT is supported by NHLBI R01HL125486 and NIDDK R01DK114735. ANT, RS, and HSD are supported by Massachusetts General Hospital’s Center for Genomic Medicine Catalysis Award. HSD and RS are supported by NIDDK R01DK107859. RS is also supported by NIDDK R01DK102696 and MGH Research Scholar Fund. The project was supported by NIH 1UL1TR001102. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Abbreviations: BMI, body mass index; CNS, central nervous system; CI, confidence interval; GPS, genome-wide polygenic score; GWAS, genome-wide association study; HGDP, Human Genome Diversity Project; HRC, Haplotype Reference Consortium; MGH, Massachusetts General Hospital; OR, odds ratio; PRS, polygenic risk score; SNP, single nucleotide polymorphism; STROBE, Strengthening the Reporting of Observational Studies in Epidemiology
Genetics play a role in the development of obesity and cardiometabolic disease , yet the influence of genetic risk for obesity on food choice behaviors is not well understood. The heritability of body mass index (BMI) is estimated to range from 47% to 90% . BMI-associated genetic variants, either independently (i.e., FTO, MC4R) or in aggregate (i.e., in the form of a polygenic risk score [PRS]), have also been linked with self-reported eating-related traits and behaviors, including increased appetite, reduced satiety, uncontrolled eating, and emotional eating [3–6]. Self-reported behaviors, however, are prone to misreporting or social desirability biases . Thus, it remains unclear whether genetic risk for obesity is associated with quality, quantity, or timing of food choices, each of which may mediate the relationship between the risk alleles and obesity.
A genome-wide association study (GWAS) in over 300,000 adult participants identified 97 common independent genetic variants that are associated with BMI . More than half of these 97 variants are enriched for expression in regions of the central nervous system (CNS), including hypothalamus circuits that regulate appetite, whereas the remaining span other tissues with unlikely CNS functions [8,9]. Recently, it was demonstrated that a genome-wide polygenic score (GPS) comprising all 2.1 million common variants across the genome accounted for up to 20% of the variation in BMI , and this may provide a more robust score to detect obesity-related associations with dietary behaviors.
Previous large cohort studies have demonstrated that consumption of sugar-sweetened beverages accentuated genetic risk for obesity, whereas consumption of a healthier diet attenuated genetic risk for obesity [10,11]. These studies concluded that genetic risk for obesity is modified by dietary environmental exposures. However, it remains unknown if genetic risk for obesity directly influences food choice behaviors and dietary intake. Obesity-implicated genetic variants may influence eating behaviors and obesity through a range of biological mechanisms that determine taste preferences, satiety, and cognitive and physiological responses to food and food cues [11–15]. Therefore, genetic predisposition to food choice behaviors may be in the causal pathway between genetic risk and the development of obesity, and genetic variants with CNS and non-CNS functions may contribute differentially to food choice behaviors.
Workplace cafeteria purchasing data provided an opportunity for objective, real-time assessment of employees’ food choices. Prior research demonstrated that the healthfulness of workplace food purchases was associated with employees’ overall dietary quality and health . We hypothesized that higher obesity genetic risk was associated with food purchasing patterns and self-reported dietary behaviors that contribute to weight gain and obesity.
Therefore, the aim of the current study was examine associations between obesity genetic risk and food choice behaviors using objectively assessed workplace food purchases (quality, quantity, and timing) collected at baseline from a cohort of employees who enrolled in a workplace health-promotion trial . We also assessed whether higher CNS-related obesity genetic risk may be more likely to be associated with food behavioral choices than the non-CNS component.
This study is reported as per the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines (S1 STROBE Checklist).
Setting and participants: “ChooseWell 365” cohort
This study is a secondary analysis of baseline data collected from participants in the “ChooseWell 365” cohort, a workplace health-promotion study at Massachusetts General Hospital (MGH), prior to the start of the health-promotion intervention randomized control trial . MGH is a 999-bed teaching hospital in Boston, MA, with over 27,000 employees, who are 70% female and have a mean age of 41 years. A total of 602 MGH employees (female = 79.4%; mean [standard deviation]: age = 43.6 [12.2] years; baseline BMI = 28.3 [6.5] kg/m2) enrolled between September 2016 and February 2018 in the “ChooseWell 365” randomized controlled trial (Clinicaltrials.gov: NCT02660086) testing a workplace intervention to promote healthy food choices and prevent weight gain . Employees were eligible for the trial if they were between 20 and 75 years of age and used their employee badge to purchase cafeteria items at least 4 times per week for at least 6 weeks during a 12-week period prior to recruitment. Additional recruitment criteria have been previously described . Analyses were prospectively planned to test the associations between BMI genetic scores and food choices as outlined in the analysis plan (S1 Text). Participants provided written informed consent upon enrollment, and the study protocol was approved by Partners HealthCare Institutional Review Board (#2015P000135).
The data for the current study are restricted to participants who consented to providing genetic data and who were of European ancestry (restricted to avoid population stratification issues and to be consistent with the GWAS that were discovered in populations of European ancestry). Analyses were conducted using survey and health data collected at a baseline visit prior to the initiation of the parent trial intervention, and cafeteria data were collected retrospectively from the 3 months prior to enrollment. We used 3 months to represent typical and habitual purchases and avoid irregularities due to short-term vacations or work schedule changes. Of the 602 participants, 499 consented to have genotyping, and 397 were of European ancestry and included in the current analysis (S1 Fig).
Workplace purchases, anthropometry, and dietary variables
During the study period, the hospital campus had 6 on-site food service locations, including 3 full-service cafeterias and 3 smaller cafes (hereafter, all referred to as “cafeterias”). The cafeterias were typically open 5 or 7 days per week and offered breakfast and lunch options in the mornings through afternoons and limited snacks/side and dinner options in the evenings and overnight. More than 1,200 different food items are available over the course of a day, including meals and entrees (e.g., hot prepared meals, prepared sandwiches and salads, and pizza), a large salad bar, snacks, and desserts, as well as hot and cold beverages. All employees in the study paid for cafeteria items by payroll deduction using their employee identification badge, and purchases were tracked using cafeteria sales data .
All hospital cafeterias labeled food and beverages with traffic-light labels, as has been described in detail elsewhere [17,18], and this labeling system had been utilized at the hospital since 2010. Briefly, the traffic-light labeling system was designed by hospital nutrition staff and based on the USDA Dietary Guidelines [19,20]. Every item was labeled as red, yellow, or green based on an algorithm that factored in calories, saturated fat content, and nutrient density. A green rating connoted the highest level of healthfulness and a red rating indicated the lowest level (e.g., least healthy). Options were distributed roughly evenly between those labeled green (34%), yellow (37%), or red (29%). The average costs of red, yellow, and green items were comparable for beverages, entrees, and snacks/side items, and items across a range of prices were available in each color category .
Participants’ baseline purchases were extracted from the hospital’s cafeteria sales data for the 3 months prior to their enrollment in the randomized trial. Purchasing data included item type, time and date of purchase, and the traffic-light label color (i.e., red, yellow, green). The quality of workplace food purchases was measured with a Healthy Purchasing Score that reflected the overall healthfulness of an employee’s 3-month baseline purchases . The Healthy Purchasing Score was created by weighting purchases of red items to be 0, yellow items to be 0.5, and green items to be 1. This score has been previously validated as a proxy for overall dietary healthfulness using 24-hour dietary recalls . For interpretation purposes in this study, the Healthy Purchasing Score was converted to percentage by multiplying the score by 100 (range, 0%–100% healthy). The quantity of workplace food purchases was measured by the total number of items purchased over 3 months, as well as the number of food and beverage items, separately. Time of day of workplace food purchases was measured by using the time stamp for the purchase data during the 3-month baseline period. The median timing of breakfast purchases (first food purchased between 6 AM and 10 AM) and median time of lunch purchase (first food purchased between 11 AM and 2 PM) were estimated for each participant.
Participants’ weight and height were measured by clinical research nursing staff at the baseline visit, and BMI was calculated as weight/height2 (kg/m2). Participants also completed an online survey that provided self-reported age, sex, meal-skipping habits (“Over the PAST WEEK, on how many days did you SKIP BREAKFAST/ LUNCH/ DINNER for any reason?”; Never, 1–2 days, 3–4 days, 5–6 days, and Every day), and home-prepared meal habits (“Over the PAST WEEK, on how many days did you eat a BREAKFAST/ LUNCH/ DINNER that was prepared at home [including meals that you bring to work]?”; Never, 1–2 days, 3–4 days, 5–6 days, and Every day).
Genetic data genotyping, imputation, and quality control
DNA was extracted from blood samples collected from 499 participants and genotyped using the Infinium Global Screening (GSA) Array-24 v2.0. Imputation was performed using the Michigan Imputation server with the Haplotype Reference Consortium (HRC, Version r1.1 2016) reference panel for imputation . This HRC panel consists of 64,940 haplotypes of predominantly European ancestry. Haplotype phasing was performed using Eagle v2.3 . Low-quality genetic markers in Hardy-Weinberg disequilibrium (P < 10−6), low minor allele frequency (<0.01), and low call rate (<98%) were excluded (200,067 genetic markers excluded). Furthermore, samples were tested for low-quality genetic samples with low sample call rate (<95%) or high heterozygosity rate (>median + 3*IQR), but none were excluded.
Participant ancestry was determined using TRACE  and the Human Genome Diversity Project (HGDP)  as a reference panel. Principal component analysis outliers were determined by using a principal component analysis projection of the study samples onto the HGDP reference samples and were subsequently excluded from analysis (n = 100 excluded). To correct for population stratification, we computed principal components of ancestry using TRACE  in the subset with genetically European ancestry. Furthermore, sample relatedness was determined using PLINK , and subsequently, 1 sample from each detected related pair (pi-hat > 0.25) was excluded.
Generation of PRSs
A total of 3 PRSs were generated for each participant from 97 previously identified single nucleotide polymorphisms (SNPs) at the genome-wide significance levels (P < 5 × 10−8). The BMI97 PRS comprised all 97 previously identified BMI variants . Based on the biological functions of genes in or near the 97 previously identified BMI loci, such as neuronal development process, neurotransmission, hypothalamic expression and regulatory function, and neuronal expression, 54 variants have been previously classified as CNS-related, and 43 variants have been previously classified as non-CNS-related . Accordingly, the BMICNS PRS and the BMInon-CNS PRS comprised the 54 and 43 non-overlapping BMI variants, respectively . All SNPs had a minor allele frequency >1% and an imputation quality (minimac rsq) ≥0.50. We derived the PRSs for each individual participant by summing the number of risk alleles that were each weighted by the allelic effect sizes (β-coefficients) published in the original GWAS meta-analysis with up to 339,224 individuals from 125 studies . Scaling of the individual PRSs was performed to allow interpretation of the effects as a per-1 risk allele increase in the PRS for each trait (division by twice the sum of the β-coefficients and multiplication by twice the square of the SNP count representing the maximum number of risk alleles).
Generation of GPS
We generated a BMI GPS for each individual by summing BMI-increasing risk alleles across the genome, each weighted by the beta estimate for that allele from the BMI GWAS meta-analyses . Only SNPs with a minor allele frequency >1% and an imputation quality (minimac rsq) ≥0.50 were considered in the GPS. Thus, we included 1,988,363 SNPs after excluding X chromosome variants and, at each site, clumped SNPs based on association P value (the variant with the smallest P value within a 250-kb range was retained and all those in linkage disequilibrium, r2 > 0.1, were removed). Linkage disequilibrium clumping and GPS generation were conducted using PRSice , and the best-fit genome-wide BMI GPS based on this cohort’s inverse normalized BMI encompassed 64,952 SNPs at P value threshold of 0.19. In sensitivity analyses, we also generated BMI GPS based on other P value thresholds (1.00 [SNPs n = 126,161], 0.50 [SNPs n = 98,995], and 0.25 [SNPs n = 73,412]) and re-ran analyses.
Non-normally distributed outcome variables (BMI and purchase data) were inverse normalized prior to analysis. Breakfast-, lunch-, and dinner-skipping variables from surveys were dichotomized to daily eaters (never skip) and skippers (skip 1 or more meal per week). Breakfast, lunch, and dinner “prepared at home” variables were dichotomized to fewer than 3 days of home meals per week or 3 or more days of home meals per week. Genetic score quartiles (e.g., Q1 = lowest genetic risk, Q4 = highest genetic risk) were generated based on the population distribution, with the highest quartile representing the more adverse phenotype (higher BMI). As enrollment was year-round, sine and cosine functions of the date of enrollment were used to adjust for seasonality in the participants’ 3-month purchasing periods . The GPS was standardized to have a mean of 0 and a standard deviation of 1. Multivariable linear regression was used to test the association of each continuous, scaled PRS or GPS quartiles with BMI adjusted for age, sex, and 5 principal components of ancestry (identified by TRACE). In addition, multivariable linear or logistic regression was used to test genetic score associations with workplace purchases and survey-derived meal habits adjusted for age, sex, seasonality, and 5 principal components of ancestry. Differences across quartiles were evaluated for significance using a test for trend. We tested for statistical interaction between CNS-related and non-CNS-related results from stratified analyses (Pint). Associations with purchases and meal habits were also repeated using continuous measures of the genetic scores. We present unadjusted (P) and false discovery rate–corrected P values (Padj) to account for multiple testing. In sensitivity analyses, we further adjusted for job type (administrative/service, craft/technicians, management/professionals, MDs/PhDs), education level (high school/some college, college degree, graduate degree), current smoking status, and physical activity level (measured with the International Physical Activity Questionnaire  at the baseline visit). All genetic analyses were conducted in R version 3.6.2 (2019 December 12), and associations were considered significant at P < 0.05.
Genetic analyses were restricted to 397 unrelated participants of European ancestry with high-quality genetic data in the “ChooseWell 365” study (Table 1, S1 Fig). The mean age of participants included in this analysis was 44.9 years, and 80.9% were female. The medians (ranges) for the number of BMI-increasing alleles observed were 90 (70–105) for BMI97, 57 (42–70) for BMICNS, and 33 (22–44) for BMInon-CNS (S2 Fig).
The GPS (BMIGPS) accounted for 14.8% of variance in BMI. The 97 loci (BMI97) accounted for 2.2% of variance in BMI, consistent with earlier reports , and the BMICNS and BMInon-CNS accounted for 1.2% and 0.5% of the BMI variance, respectively. Of the 97 BMI loci, 56 signals showed a direction of association consistent with the discovery GWAS (binomial P = 0.03) (S1 Table). Generally, higher quartiles of the genetic scores were consistently associated with higher BMI (Fig 1). The highest quartile (Q4) of the BMIGPS was associated with a 6.4-kg/m2-higher (95% confidence interval [CI] 4.8–8.0) BMI relative to the lowest quartile (Q1) (P = 2.1 × 10−15). By comparison, the highest quartiles of the BMI97, BMICNS, and BMInon-CNS PRS were associated with a 2.4-kg/m2-higher (95% CI 0.7–4.1; P = 0.01), 1.9-kg/m2-higher (95% CI 0.2–3.6; P = 0.10), and 1.9-kg/m2-higher (95% CI 0.2–3.6; P = 0.04) BMI relative to the lowest quartile, respectively.
Higher quartiles reflect more BMI-increasing alleles. y-Axis is difference in BMI (in kg/m2) compared with reference quartile (Q1) adjusted for age, sex, and 5 principal components of ancestry. Asterisks denote significant (i.e., P < 0.05) difference between quartile and Q1. The BMIGPS is a GPS comprising 36,172 BMI-increasing risk alleles across the entire genome. The BMI97 PRS is restricted to 97 previously identified BMI variants at the genome-wide threshold . Based on the biological functions of genes in or near the 97 previously identified BMI loci, the BMICNS PRS and BMInon-CNS PRS comprise 54 variants previously classified as CNS-related and 43 variants previously classified as non-CNS-related, respectively . For interpretation purposes, difference in BMI is derived from models in which BMI is untransformed, whereas P values are derived from models in which BMI is inverse normalized. BMI, body mass index; CNS, central nervous system; GPS, genome-wide polygenic score; OR, odds ratio; PRS, polygenic risk score.
Fig 2 shows associations between the BMIGPS and the BMI97 genetic scores and workplace purchases (quality, quantity, and timing). The highest quartile of the BMIGPS was associated with a lower Healthy Purchasing Score relative to the lowest quartile of the BMIGPS (−4.8 percentage points [95% CI −8.6 to −1.0]; P = 0.02). The highest quartile of the BMIGPS was also associated with purchasing more food items over the 3-month period (14.4 more items [95% CI −0.1 to 29.0]; P = 0.03) and with purchasing breakfast later (15.0 minutes later [95% CI 1.5–28.5]; P = 0.03) than the lowest quartile of BMIGPS. There were no significant associations between the BMI97 and workplace food purchases. Fig 3 shows associations between purchases and BMICNS and BMInon-CNS risk scores. Significant heterogeneity between CNS and non-CNS was observed for the associations for total purchases (Pint = 0.02), food purchases (Pint = 0.03), and breakfast timing (Pint = 0.04). Relative to the lowest quartile, the highest BMICNS quartile was associated with fewer total (−18.5 items [95% CI −38.4 to 1.4]; P = 0.04) and food items (−12.6 food items [95% CI −27.2 to 2.0]; P = 0.04) purchased at work, and the highest BMInon-CNS quartile was associated with purchasing breakfast later than the lowest quartile (17.9 minutes later [95% CI 4.5–31.3]; P = 0.01).
Association results are adjusted betas reflecting difference in Healthy Purchasing Score (percentage), items purchased (units over 3-month period), or timing (in minutes) between highest (Q4) and lowest (Q1, reference) quartile of BMI genetic scores adjusted for age, sex, seasonality, and 5 principal components of ancestry. Higher purchasing score = healthier purchases (0%–100%). For interpretation purposes, adjusted betas are from models in which outcomes are untransformed, whereas P values are derived from models in which outcomes are inverse normalized. P values are unadjusted for multiple testing, and false discovery rate–corrected P values (Padj) are presented in S2 Table. BMI, body mass index; CI, confidence interval; GPS, genome-wide polygenic score.
Association results are adjusted betas reflecting difference in Healthy Purchasing Score (percentage), items purchased (units over 3-month period), or timing (in minutes) between highest (Q4) and lowest (Q1, reference) quartile of BMI genetic scores adjusted for age, sex, seasonality, and 5 principal components of ancestry. Higher purchasing score = healthier purchases (0%–100%). For interpretation purposes, adjusted betas are from models in which outcomes are untransformed, whereas P values are derived from models in which outcomes are inverse normalized. P values are unadjusted for multiple testing, and false discovery rate–corrected P values (Padj) are presented in S2 Table. Based on the biological functions of genes in or near the 97 previously identified BMI loci, the BMICNS PRS and BMInon-CNS PRS comprise 54 variants previously classified as CNS-related and 43 variants previously classified as non-CNS-related, respectively. BMI, body mass index; CI, confidence interval; CNS, central nervous system; GPS, genome-wide polygenic score; int, interaction; PRS, polygenic risk score.
Associations between the BMI genetic scores and self-reported meal skipping or meals prepared at home are demonstrated in Fig 4 and Fig 5. Higher BMIGPS was associated with lower odds of preparing dinner at home (Q4 odds ratio [OR] = 0.3 [95% CI 0.1–0.9]; P = 0.03), and no significant associations between the BMI97 genetic scores and meal skipping or meals prepared at home were observed (Fig 4). In addition, BMInon-CNS was associated with higher odds of skipping breakfast (Q4 OR = 2.0 [95% CI 1.1–3.7]; P = 0.03) and lower odds of preparing breakfast (Q4 OR = 0.5 [0.3–1.0]; P = 0.04) or lunch (Q4 OR = 0.4 [0.2–0.8]; P = 0.01) at home, with significant heterogeneity between CNS and non-CNS associations observed for preparing lunch at home only (Pint = 0.004) (Fig 5).
Association results are adjusted odds ratio comparing highest (Q4) with lowest (Q1) quartile of BMI genetic scores adjusted for age, sex, seasonality, and 5 principal components of ancestry. Odds ratio >1 indicates more meal skipping or more meals prepared at home. P values are unadjusted for multiple testing, and false discovery rate–corrected P values (Padj) are presented in S2 Table. BMI, body mass index; CI, confidence interval; GPS, genome-wide polygenic score.
Association results are adjusted odds ratio comparing highest (Q4) with lowest (Q1) quartile of BMI genetic scores adjusted for age, sex, seasonality, and 5 principal components of ancestry. Odds ratio >1 indicates more meal skipping or more meals prepared at home. P values are unadjusted for multiple testing, and false discovery rate–corrected P values (Padj) are presented in S2 Table. BMI, body mass index; CI, confidence interval; CNS, central nervous system; GPS, genome-wide polygenic score; int, interaction.
Accounting for multiple testing resulted in Padj greater than 0.05 for all findings (S2 Table). In sensitivity analyses, results were similar when BMI genetic scores were expressed as continuous measures (S3 Table); when these models were further adjusted for job type, education level, smoking status, and physical activity level in sensitivity analyses (S4 Table); and when the BMIGPS was calculated using other P value thresholds (S5 Table).
In this study, we used objective, real-time food purchasing data to investigate the association of food choice behaviors with genetic risk for obesity. Using genetic risk scores derived with variants from a previous BMI GWAS meta-analysis, we found evidence that employees’ genetic risk was associated with the quality, quantity, and timing of the food they purchased at work. Higher genetic risk was associated with several workplace food choice behaviors that may contribute to weight gain and obesity, including purchasing less healthy food; purchasing larger quantities of food; purchasing meals at later times; skipping breakfast; and being less likely to prepare meals at home. Prior research has demonstrated that lifestyle modification may attenuate genetic susceptibility to obesity and cardiometabolic risk [11,30,31], and therefore our preliminary findings may have important implications for tailoring health-promotion and workplace wellness programs in the future.
Overall, BMIGPS had the strongest associations with BMI and food choice behaviors. Higher BMIGPS was associated with a lower Healthy Purchasing Score, a measure of the dietary quality of workplace food that has been correlated with overall dietary quality, as measured by 24-hour dietary recalls . The reasons for associations between higher genetic risk and purchasing more unhealthy foods at work are likely multifactorial and may include individual preferences for less healthy foods (e.g., foods high in saturated fat or sugar) , impulsive behavior , and vulnerability to unhealthy cues in the food environment . These associations are consistent with prior studies demonstrating that higher numbers of FTO obesity-related risk alleles were associated with more eating episodes per day, higher calories consumed at lunch, and stronger responses to food cues [14,34,35]. Other loci have established roles in anorexigenic and orexigenic signaling pathways (BDNF) , nutrient preference such as carbohydrate (RARB)  and fat (ADH1B) , and energy homeostasis (MTCH2) . Our findings, however, do not implicate specific genes or mechanisms, and the precise biological role of most BMI loci remain to be elucidated .
Higher BMIGPS was also associated with purchasing more food items at work and being less likely to prepare dinner at home, a behavior previously associated with obesity in adults . Lastly, the association between higher genetic risk and later breakfast purchases corroborates earlier nongenetic epidemiological findings between higher BMI and later food intake [40,41]. The greater number of significant associations observed for the BMIGPS relative to the BMI97 may be due to the fact that the BMIGPS explained 6 times more BMI variance than the BMI97, resulting in a more robust genetic risk score and possibly capturing more of the underlying biology for BMI. Several findings for the BMI97 were consistent in direction with the BMIGPS and may require a larger sample size before significant associations are detected. Collectively, these findings suggest that genetic risk for obesity may play a role in vulnerability to food behaviors that contribute to weight gain.
To further explore the association of genetic risk for obesity and food choice, we examined differences by the 97 genetic variants for BMI that are enriched for expression in regions of the CNS compared with the remaining variants that are expressed in other tissues with non-CNS functions. Prior research provided evidence indicating possible differential effects of these subsets, with BMICNS having a stronger interaction with dietary quality on BMI than BMInon-CNS . In our study, we observed subset differences in the quantity of food purchased at work, with higher BMICNS associated with purchasing fewer food items at work and higher BMInon-CNS trending toward purchasing more food items at work. Higher BMInon-CNS was associated with purchasing breakfast at a later time, skipping breakfast, and not preparing breakfast or lunch at home, but BMICNS was not associated with any of these factors. Contrary to our initial hypothesis, our results suggest that BMInon-CNS had a stronger association with employees’ food choice behaviors that could lead to weight gain than BMICNS. Given that the workplace food environment in this study utilized cues to promote healthier eating (i.e., traffic-light labels), it is possible that these cues may have attenuated the unhealthy food choice behaviors of employees with higher BMICNS but did not interact with behaviors of employees with higher BMInon-CNS. Although these preliminary findings will need to be confirmed in larger samples, our results may have implications for tailoring interventions for subgroups of individuals, and insights could be leveraged to unravel and classify subtypes of BMI genetic risk, as has been conducted for other diseases such as diabetes .
A major strength of this study is the objective and comprehensive assessment of workplace food purchases derived from 3 months of cafeteria sales data. These measures were not prone to misreporting or social desirability biases, in contrast to many prior studies in the field. Our approach also enabled a multidimensional capture of food choice behavior, including timing. Furthermore, the relevant self-reported dietary behavior provided results that were complementary to the cafeteria purchasing findings.
There are also important limitations. Although the cafeteria systems provided objective data, food purchases may not have reflected actual food consumption that may have been influenced by work shift schedules and cafeteria hours. The BMICNS and BMInon-CNS designations were limited to the 97 previously characterized BMI genetic variants, but additional variants may be missing from these genetic scores. We primarily present P values unadjusted for multiple testing because of our modest sample size and because the BMI genetic risk scores and the outcomes tested were not independent. Therefore, we acknowledge that individual “significant” findings should be interpreted with caution, since accounting for multiple comparisons led to nonsignificant P values, and that larger samples are necessary to verify our findings. Although the types of data we collected suggest we could infer potential causal links using mendelian randomization analyses, our sample size is too small for such an approach. Selection bias was possible as a result of inclusion and exclusion criteria for the randomized trial in addition to the criteria for this analysis, such as non-European ancestry (restricted to avoid population stratification issues). Also, despite our covariate adjustment, we recognize that a general weakness of observational studies is a risk of bias due to residual confounding. Finally, our sample consisted of a relatively small number of healthy working adults at a large urban hospital who had volunteered to enroll in a health-promotion study, which may limit generalizability of our findings to other working populations and rural or non-employed people.
In conclusion, this study identified associations between obesity genetic risk scores and food choice behaviors, suggesting that the genetic risk for obesity may play a role in vulnerability to food behaviors that are relevant for the development of obesity. Our findings demonstrated that higher genetic risk for BMI was associated with workplace food choice behaviors that may contribute to weight gain. Prior research has shown that healthy lifestyle behaviors, including dietary intake, can attenuate weight gain and cardiovascular disease in those at high genetic risk [11,30,31]. Therefore, understanding genetic predisposition to certain food choice behaviors that contribute to cardiometabolic disease could inform interventions that are tailored to changing individuals’ dietary habits.
S1 STROBE Checklist. STROBE checklist.
STROBE, Strengthening the Reporting of Observational Studies in Epidemiology.
S1 Table. Individual 97 BMI single nucleotide polymorphism associations with BMI (in kg/m2) in the “ChooseWell 365” study (n = 397).
BMI, body mass index.
S2 Table. Unadjusted (Punadj) and false discovery rate–corrected (Padj) P values for BMI genetic scores associations with workplace purchases and self-reported meal skipping and meals prepared at home.
BMI, body mass index.
S3 Table. BMI genetic scores as continuous measures associations with workplace purchases and self-reported meal skipping and meals prepared at home.
BMI, body mass index.
S4 Table. Sensitivity analyses for BMI genetic scores associations with workplace purchases and self-reported meal skipping and meals prepared at home further adjusted for job type, education level, smoking status, and physical activity level.
S5 Table. Sensitivity analyses for BMI GPS associations with workplace purchases and self-reported meal skipping and meals prepared at home based on other P value thresholds (P = 0.25; 0.50; 1.00).
BMI, body mass index; GPS, genome-wide polygenic score.
S1 Fig. Flow chart of included “ChooseWell 365” study participants in present analysis.
- 1. Loos RJ. The genetics of adiposity. Current Opinion in Genetics and Development. Elsevier; 2018. pp. 86–95. pmid:29529423
- 2. Elks CE, den Hoed M, Zhao JH, Sharp SJ, Wareham NJ, Loos RJF, et al. Variability in the heritability of body mass index: a systematic review and meta-regression. Front Endocrinol (Lausanne). 2012;3: 29. pmid:22645519
- 3. de Lauzon-Guillain B, Clifton EA, Day FR, Clément K, Brage S, Forouhi NG, et al. Mediation and modification of genetic susceptibility to obesity by eating behaviors. Am J Clin Nutr. 2017;106: 996–1004. pmid:28814400
- 4. Cornelis MC, Rimm EB, Curhan GC, Kraft P, Hunter DJ, Hu FB, et al. Obesity susceptibility loci and uncontrolled eating, emotional eating and cognitive restraint behaviors in men and women. Obesity. 2014;22: E135–E141. pmid:23929626
- 5. Tanofsky-Kraff M, Han JC, Anandalingam K, Shomaker LB, Columbo KM, Wolkoff LE, et al. The FTO gene rs9939609 obesity-risk allele and loss of control over eating. Am J Clin Nutr. 2009;90: 1483–1488. pmid:19828706
- 6. Merino J, Dashti HS, Li SX, Sarnowski C, Justice AE, Graff M, et al. Genome-wide meta-analysis of macronutrient intake of 91,114 European ancestry participants from the cohorts for heart and aging research in genomic epidemiology consortium. Mol Psychiatry. 2018 [cited 30 Jul 2018]. pmid:29988085
- 7. Althubaiti A. Information bias in health research: Definition, pitfalls, and adjustment methods. Journal of Multidisciplinary Healthcare. 2016;9: 211–217. pmid:27217764
- 8. Locke AE, Kahali B, Berndt SI, Justice AE, Pers TH, Day FR, et al. Genetic studies of body mass index yield new insights for obesity biology. Nature. 2015;518: 197–206. pmid:25673413
- 9. Berthoud H-R, Morrison C. The brain, appetite, and obesity. Annu Rev Psychol. 2008;59: 55–92. pmid:18154499
- 10. Qi Q, Chu AY, Kang JH, Jensen MK, Curhan GC, Pasquale LR, et al. Sugar-sweetened beverages and genetic risk of obesity. N Engl J Med. 2012;367: 1387–96. pmid:22998338
- 11. Ding M, Ellervik C, Huang T, Jensen MK, Curhan GC, Pasquale LR, et al. Diet quality and genetic association with body mass index: results from 3 observational studies. Am J Clin Nutr. 2018;108: 1291–1300. pmid:30351367
- 12. Moon J-Y, Wang T, Sofer T, North KE, Isasi CR, Cai J, et al. Objectively Measured Physical Activity, Sedentary Behavior, and Genetic Predisposition to Obesity in U.S. Hispanics/Latinos: Results From the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). Diabetes. 2017;66: 3001–3012. pmid:28986399
- 13. Robino A, Concas MP, Catamo E, Gasparini P. A Brief Review of Genetic Approaches to the Study of Food Preferences: Current Knowledge and Future Directions. Nutrients. 2019;11: 1735. pmid:31357559
- 14. Ranzenhofer LM, Mayer LES, Davis HA, Mielke‐Maday HK, McInerney H, Korn R, et al. The FTO Gene and Measured Food Intake in 5‐ to 10‐Year‐Old Children Without Obesity. Obesity. 2019;27: 1023–1029. pmid:31119882
- 15. van der Klaauw AA, Keogh JM, Henning E, Stephenson C, Kelway S, Trowse VM, et al. Divergent effects of central melanocortin signalling on fat and sucrose preference in humans. Nat Commun. 2016;7: 13055. pmid:27701398
- 16. McCurley JL, Levy DE, Rimm EB, Gelsomin ED, Anderson EM, Sanford JM, et al. Association of Worksite Food Purchases and Employees’ Overall Dietary Quality and Health. Am J Prev Med. 2019;57: 87–94. pmid:31128960
- 17. Levy DE, Gelsomin ED, Rimm EB, Pachucki M, Sanford J, Anderson E, et al. Design of ChooseWell 365: Randomized controlled trial of an automated, personalized worksite intervention to promote healthy food choices and prevent weight gain. Contemp Clin Trials. 2018;75: 78–86. pmid:30414448
- 18. Thorndike AN, Sonnenberg L, Riis J, Barraclough S, Levy DE. A 2-phase labeling and choice architecture intervention to improve healthy food and beverage choices. Am J Public Health. 2012;102: 527–33. pmid:22390518
- 19. Frankenfeld CL, Poudrier JK, Waters NM, Gillevet PM, Xu Y. Dietary Intake Measured from a Self-Administered, Online 24-Hour Recall System Compared with 4-Day Diet Records in an Adult US Population. J Acad Nutr Diet. 2012;112: 1642–1647. pmid:22878341
- 20. Subar AF, Kirkpatrick SI, Mittl B, Zimmerman TP, Thompson FE, Bingley C, et al. The Automated Self-Administered 24-hour dietary recall (ASA24): a resource for researchers, clinicians, and educators from the National Cancer Institute. J Acad Nutr Diet. 2012;112: 1134–7. pmid:22704899
- 21. McCarthy S, Das S, Kretzschmar W, Delaneau O, Wood AR, Teumer A, et al. A reference panel of 64,976 haplotypes for genotype imputation. Nat Genet. 2016;48: 1279–83. pmid:27548312
- 22. Loh PR, Danecek P, Palamara PF, Fuchsberger C, Reshef YA, Finucane HK, et al. Reference-based phasing using the Haplotype Reference Consortium panel. Nat Genet. 2016;48: 1443–1448. pmid:27694958
- 23. Wang C, Zhan X, Liang L, Abecasis GR, Lin X. Improved ancestry estimation for both genotyping and sequencing data using projection procrustes analysis and genotype imputation. Am J Hum Genet. 2015;96: 926–37. pmid:26027497
- 24. Cann HM, de Toma C, Cazes L, Legrand M-F, Morel V, Piouffre L, et al. A human genome diversity cell line panel. Science. 2002;296: 261–2. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11954565 pmid:11954565
- 25. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81: 559–75. pmid:17701901
- 26. Qi Q, Chu AY, Kang JH, Huang J, Rose LM, Jensen MK, et al. Fried food consumption, genetic risk, and body mass index: gene-diet interaction analysis in three US cohort studies. BMJ. 2014;348: g1610. pmid:24646652
- 27. Euesden J, Lewis CM, O’Reilly PF. PRSice: Polygenic Risk Score software. Bioinformatics. 2015;31: 1466–8. pmid:25550326
- 28. Stolwijk AM, Straatman H, Zielhuis GA. Studying seasonality by using sine and cosine functions in regression analysis. J Epidemiol Community Health. 1999;53: 235–8. pmid:10396550
- 29. Hagströmer M, Oja P, Sjöström M. The International Physical Activity Questionnaire (IPAQ): a study of concurrent and construct validity. Public Health Nutr. 2006;9: 755–762. pmid:16925881
- 30. Wang T, Heianza Y, Sun D, Huang T, Ma W, Rimm EB, et al. Improving adherence to healthy dietary patterns, genetic risk, and long term weight gain: gene-diet interaction analysis in two prospective cohort studies. BMJ. 2018;360: j5644. pmid:29321156
- 31. Khera A V, Emdin CA, Kathiresan S. Genetic Risk, Lifestyle, and Coronary Artery Disease. N Engl J Med. 2017;376: 1192–1195. pmid:28332385
- 32. Meyre D, Mohamed S, Gray JC, Weafer J, MacKillop J, de Wit H. Association between impulsivity traits and body mass index at the observational and genetic epidemiology level. Sci Rep. 2019;9: 17583. pmid:31772290
- 33. Roberts SB, Das SK, Suen VMM, Pihlajamäki J, Kuriyan R, Steiner-Asiedu M, et al. Measured energy content of frequently purchased restaurant meals: multi-country cross sectional study. BMJ. 2018;363: k4864. pmid:30541752
- 34. McCaffery JM, Papandonatos GD, Peter I, Huggins GS, Raynor HA, Delahanty LM, et al. Obesity susceptibility loci and dietary intake in the Look AHEAD Trial. Am J Clin Nutr. 2012;95: 1477–86. pmid:22513296
- 35. Rapuano KM, Zieselman AL, Kelley WM, Sargent JD, Heatherton TF, Gilbert-Diamond D. Genetic risk for obesity predicts nucleus accumbens size and responsivity to real-world food cues. Proc Natl Acad Sci U S A. 2017;114: 160–165. pmid:27994159
- 36. Rios M. Special issue: neural control of appetite BDNF and the central control of feeding: accidental bystander or essential player? Trends Neurosci. 2013;36: 83–90. pmid:23333344
- 37. Meddens SFW, de Vlaming R, Bowers P, Burik CAP, Linnér RK, Lee C, et al. Genomic analysis of diet composition finds novel loci and associations with health and lifestyle. Mol Psychiatry. 2020. pmid:32393786
- 38. Buzaglo-Azriel L, Kuperman Y, Tsoory M, Haran M, Vernochet C, Gross Correspondence A, et al. Loss of Muscle MTCH2 Increases Whole-Body Energy Utilization and Protects from Diet-Induced Obesity. CellReports. 2016;14: 1602–1610. pmid:26876167
- 39. Tumin R, Anderson SE. Television, Home-Cooked Meals, and Family Meal Frequency: Associations with Adult Obesity. J Acad Nutr Diet. 2017;117: 937–945. pmid:28242429
- 40. Baron KG, Reid KJ, Kern AS, Zee PC. Role of Sleep Timing in Caloric Intake and BMI. Obesity. 2011;19: 1374–1381. pmid:21527892
- 41. Garaulet M, Gómez-Abellán P, Alburquerque-Béjar JJ, Lee Y-C, Ordovás JM, Scheer FAJL. Timing of food intake predicts weight loss effectiveness. Int J Obes (Lond). 2013;37: 604–11. pmid:23357955
- 42. Udler MS, Kim J, von Grotthuss M, Bonàs-Guarch S, Cole JB, Chiou J, et al. Type 2 diabetes genetic loci informed by multi-trait associations point to disease mechanisms and subtypes: A soft clustering analysis. PLoS Med. 2018;15: e1002654. pmid:30240442